Vigabatrin (γ-Vinyl-GABA), an inhibitory neurotransmitter GABA vinyl-derivative, is an orally active and irreversible GABA transaminase inhibitor.
Vigabatrin (γ-Vinyl-GABA), an inhibitory neurotransmitter GABA vinyl-derivative, is an orally active and irreversible GABA transaminase inhibitor.
Vigabatrin hydrochloride (γ-Vinyl-GABA hydrochloride), a inhibitory neurotransmitter GABA vinyl-derivative, is an orally active and irreversible GABA transaminase inhibitor.
Vigabatrin hydrochloride (γ-Vinyl-GABA hydrochloride), a inhibitory neurotransmitter GABA vinyl-derivative, is an orally active and irreversible GABA transaminase inhibitor.
Vigabatrin hydrochloride (γ-Vinyl-GABA hydrochloride), a inhibitory neurotransmitter GABA vinyl-derivative, is an orally active and irreversible GABA transaminase inhibitor.
Vilanterol(GW642444, Veranterol) is a long-acting β2-AR agonist. PEC50 of β2-AR, β1-AR and β3-AR were 10.37, 6.98, 7.36, respectively.
Vilanterol(GW642444, Veranterol) is a long-acting β2-AR agonist. PEC50 of β2-AR, β1-AR and β3-AR were 10.37, 6.98, 7.36, respectively.
Vilanterol(GW642444, Veranterol) is a long-acting β2-AR agonist. PEC50 of β2-AR, β1-AR and β3-AR were 10.37, 6.98, 7.36, respectively.
Vilanterol(GW642444, Veranterol) is a long-acting β2-AR agonist. PEC50 of β2-AR, β1-AR and β3-AR were 10.37, 6.98, 7.36, respectively.
Vilanterol trifenatate is a novel, long-acting β(2)-adrenoceptor (β(2)-AR) agonist with 24 h activity.
Vilanterol trifenatate is a novel, long-acting β(2)-adrenoceptor (β(2)-AR) agonist with 24 h activity.
Vilanterol trifenatate is a novel, long-acting β(2)-adrenoceptor (β(2)-AR) agonist with 24 h activity.